Cartersville Clinic - Drug Rehab

CRC Health Group - Experts in Behavioral Health and Addiction Treatment

CRC Health is the largest provider of specialized behavioral health care services in the U.S. Operating residential treatment facilities, outpatient clinics, boarding schools, outdoor wilderness camps, and a variety of other therapeutic programs, we are uniquely qualified to treat patients throughout the life cycle of their disorders, at every level of care.

National, Accredited Behavioral Health Treatment for:
* Substance Abuse
* Struggling Youth
* Eating Disorders
* Weight Management

Providing a standard of excellence in the treatment of addiction and related behavioral health disorders

CRC Health Group is the nation's leading provider of treatment and educational programs for adults and youth who are struggling with behavioral issues, chemical dependency, eating disorders, obesity, pain management, or learning disabilities. Whether you are seeking addiction treatment for an adult or a specialized learning environment for your child, we are sure to have a program that will meet your needs. For more than 30 years, our treatment philosophy and exceptional care have enabled our clients to reclaim and enrich their lives.

Cartersville Clinic
218 Stonewall St
Cartersville GA 30120
Tel: 770 386-1907

Treatment Services
* Methadone/Suboxone Maintenance

The Cartersville Center provides medically supervised methadone maintenance and Suboxone (buprenorphine) detox treatment to individuals who are attempting to overcome an addiction to or dependence upon heroin or other opioids.

Methadone hydrochloride is a synthetic "opioid agonist," which means that it acts in a way that is similar to morphine and other narcotic medications. When used in proper doses as part of a medically supervised opioid addiction treatment program, methadone blocks cravings and other withdrawal symptoms without creating the euphoric or sedative states that result from opioid abuse.

Buprenorphine is a partial opioid receptor agonist. Like methadone, buprenorphine can relieve opioid withdrawal symptoms without producing the intoxicating effects that are associated with opioid abuse. Buprenorphine was the first medication for the treatment of opioid dependence to be approved under the Drug Addiction Treatment Act of 2000.

To be eligible for this type of treatment at the Cartersville Center, prospective patients much be at least 18 years old, and must have been addicted to or dependent upon opiates for a minimum of one year prior to seeking treatment.